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Introduction: Splenic artery pseudoaneurysm is uncommon. We report our institution’s recent 18-year experience with
these aneurysms and review the literature.
Methods: We reviewed the records for 37 patients with visceral artery pseudoaneurysm evaluated at our institution from
1980 to 1998. From this group we found only 10 patients (27%) with splenic artery pseudoaneurysm. We also reviewed
147 cases of splenic artery pseudoaneurysm reported in the English literature.
Results: In this series of 10 patients, 5 were men. Mean age was 51.2 years (range, 35-78 years). Causes of aneurysm
included chronic pancreatitis in 4 patients, trauma in 2 patients, iatrogenic cause in 1 patient, and unknown cause in 3.
The most common symptom was bleeding in 7 patients and abdominal or flank pain in 5 patients; 2 patients had no
symptoms. Aneurysm diameter was known for four pseudoaneurysms, and ranged from 0.3 to 3 cm (mean, 1.7 cm).
Splenectomy and distal pancreatectomy were performed in 4 patients, splenectomy alone in 2 patients, endovascular
transcatheter embolization in 2 patients, and simple ligation in 1 patient. One patient with a ruptured pseudoaneurysm
died before any intervention could be performed; there were no postoperative deaths. Follow-up data were available for
7 patients, with a mean of 46.3 months (range, 4.5-120 months).
Conclusions: Splenic artery pseudoaneurysm is rare and usually is a complication of pancreatitis or trauma. Average
aneurysm diameter in our series of 10 patients was smaller than previously reported (1.7 cm vs 5.0 cm). Although
conservative management has produced excellent results in some reports, from our experience and the literature, we
recommend repair of all splenic artery pseudoaneurysms. (J Vasc Surg 2003;38:969-74.)
Visceral artery aneurysm is uncommon. The visceral
arteries are the sixth most common site for arterial aneurys-
mal degeneration. Visceral artery pseudoaneurysm is even
more uncommon. The most commonly reported visceral
aneurysm involves the splenic artery.1 Similarly, the splenic
artery is the artery most commonly affected with pseudo-
aneurysm, followed by the hepatic artery, celiac artery, and
more rarely other visceral arteries. The largest series of
visceral artery aneurysms and pseudoaneurysms reported
30 to 40 cases, of which pseudoaneurysm constituted only
a small fraction. To better establish the cause, presenting
symptoms, and management options, we performed a ret-
rospective review of our experience, as well as a cumulative
review of the English literature.
METHODS
A retrospective review was undertaken of charts for all
patients seen at our institutions, including Mayo Clinic
Rochester, Scottsdale, and Jacksonville, between January
1980 and December 1998. Charts of all patients with
visceral artery pseudoaneurysm were included for review.
These were subdivided according to anatomic location.
Patients with pseudoaneurysm involving the splenic artery
composed our study group. The diagnosis of pseudoaneu-
rysm was made on the basis of pathologic studies or autopsy
data when available. When pathologic specimens were not
available (patients who underwent embolization) the diag-
nosis was obtained from patient history of abdominal
trauma, recurrent pancreatitis, acute pancreatitis, or previ-
ous surgical exploration in conjunction with a radiologic
examination. The records of all patients were reviewed with
regard to demographic data, comorbid conditions, clinical
presentation, pseudoaneurysm characteristics, imaging
studies, operative intervention, and outcome. True aneu-
rysms were specifically excluded from review. Long-term
follow-up data were obtained by chart review or by direct
phone contact with the patient or relative. No specific
protocol was followed for management of these aneurysms;
surgeon preference and judgment dictated all management
decisions.
Cumulative review of literature. The MEDLINE
(1966–March 2000) database was searched, with the key
words splenic artery, pseudoaneurysm, and false aneurysm.
Only articles published in English were included for review.
The references for each paper were also reviewed to find
other reports of splenic artery pseudoaneurysm that were
excluded in the MEDLINE search. Included for review
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were all reports of patients with pseudoaneurysm of the
splenic artery.
RESULTS
Mayo Clinic experience. Thirty-seven patients with
visceral artery pseudoaneurysm were identified in our re-
view. Ten patients (27%) had pseudoaneurysm of the
splenic artery, and made up our study group. During this
same time 217 patients underwent treatment of true aneu-
rysm of the splenic artery. Five study patients were men,
and five were women; mean age was 51.2 years (range,
35-78 years). Presumed cause included chronic pancreatitis
in 4 patients, blunt abdominal trauma in 2 patients, iatro-
genic cause in 1 patient, and unknown cause in 3 patients.
The interval between initial presentation and diagnosis of
splenic artery pseudoaneurysm ranged from 2 hours to 4
days (median, 5 hours). Bleeding was the most common
symptom, and was present in seven patients, two of whom
were hemodynamically unstable and both of whom bled
into the lesser sac. Two patients had hematemesis and
hematochezia due to bleeding into the pancreatic duct. In
another patient a fistula developed between the pseudoan-
eurysm and the left colon, resulting in hematochezia. Fi-
nally, two patients bled into the stomach. Five patients had
either abdominal or flank pain. In two patients the pseudo-
aneurysm was discovered during evaluation of another
problem.
The diagnosis of splenic artery pseudoaneurysm was
established most commonly (50%) at computed tomogra-
phy (CT). Angiography was used in three patients, and
endoscopy in one patient. One hemodynamically unstable
patient died before any diagnostic study could be per-
formed; ruptured pseudoaneurysm was diagnosed at
autopsy.
Pseudoaneurysm diameter was known in four cases,
and ranged from 0.3 to 3 cm (mean, 1.7 cm). Nine patients
underwent operative or radiologic interventions. Splenec-
tomy and distal pancreatectomy was necessary in 4 patients,
and in 1 of these patients colon resection was required to
manage a fistulous tract between the pseudoaneurysm and
left colon. Two patients underwent splenectomy only. Two
patients underwent successful transcatheter embolization,
and one patient was managed with simple ligation. One
patient had massive bleeding and died before intervention.
There were no postoperative deaths. Postoperative
complications occurred in 5 patients, including pneumonia
in 3 patients, pancreatic ductal leak in 1 patient, and acute
renal failure in 1 patient. Follow-up data were available for
seven patients, with mean follow-up of 46.3 months
(range, 4.5-120 months). No pseudoaneurysm recurred in
any patient during follow-up.
Cumulative review. Including the 10 patients in our
series, 157 cases of splenic artery pseudoaneurysm have
been reported in the English literature.1-70 Eighty-nine
patients (77.3%) were male, and 26 patients (22.7%) were
female; gender was not specified for 42 patients. The inter-
val between initial presentation and diagnosis of splenic
artery pseudoaneurysm ranged from less than 1 hour to 5
years (median, 24 hours).
Symptoms at presentation are summarized in Table I.
Seventy-four patients (47%) had bleeding. Of this group,
43 (58%) were hemodynamically unstable. The site of
bleeding was described for 59 patients, and included the
pancreatic duct (42%), stomach (22%), peritoneal cavity
(20%), and colon (15%). Causes are summarized in Table
II. Pancreatic disease (chronic pancreatitis, acute pancreati-
tis, pancreatic pseudocyst) was believed to be the cause in
82 patients (52%). Abdominal trauma was the next most
common cause (29%), and more rare causes included peptic
ulcer disease (2%) and postoperative complication (3%).
Studies used to establish the diagnosis are listed in
Table III. Angiography was the most commonly performed
diagnostic study (52%), followed by CT (36%) and ultra-
sonography (3.3%). CT angiography (0.7%), magnetic res-
onance imaging (0.7%), and plain radiography (0.7%) were
rarely used. Endoscopy was reportedly diagnostic in one
(0.7%) patient. Finally, immediate laparotomy or autopsy
was diagnostic in 10 hemodynamically unstable patients
(6.7%).
Size was known for 61 pseudoaneurysms (38.9%).
Mean diameter was 4.8 cm (range, 0.3-17 cm). Treatment
in 145 patients was described, and interventions (surgical
and radiologic) included embolization (37%), splenectomy
and distal pancreatectomy (26%), splenectomy alone
(11%), ligation alone (10%), endovascular stenting (4%),
Table I. Symptoms at presentation in patients with
splenic artery pseudoaneurysm
Symptom
Current
series (%)
(N  10)
Literature
review (%)
(N  112)
Combined (%)
(N  122)
Nausea 20 6.3 7.4
Vomiting 0 7.2 6.6
Chest pain 20 0.9 2.5
Back or flank pain 20 2.7 6.6
Abdominal pain 50 27.6 29.5
Mass 0 1.7 1.6
Hematemesis 30 13.4 14.8
Hematochezia or melena 30 25.9 26.2
Hemosucus pancreaticus 20 20.3 20.3
Incidental finding 20 0.9 2.5
Table II. Presumed cause of splenic artery
pseudoaneurysm
Cause
Current
series (%)
(N  10)
Literature
review (%)
(N  147)
Combined (%)
(N  157)
Acute pancreatitis 0 6.8 6
Chronic pancreatitis 40 46.3 46
Trauma 20 29.3 29
Peptic ulcer disease 0 2.0 2
Postoperative complication 10 2.7 3
Unknown or not reported 30 13.0 14
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ligation and splenectomy (3%), distal pancreatectomy alone
(2%), total pancreatectomy alone (1%), and splenectomy
with total pancreatectomy (1%). Eight pseudoaneurysms
(5%) were managed conservatively (no operative or radio-
logic treatment was attempted and the pseudoaneurysm
was observed on an outpatient basis), with no reported
complications at follow-up. Ligation alone failed in six
patients (43%) in which it was attempted. Three patients
underwent splenectomy, two underwent splenectomy and
distal pancreatectomy, and one underwent successful trans-
catheter embolization. Transcatheter embolization failed in
eight patients (14%). One patient underwent a second
embolization with success, and the rest underwent success-
ful splenectomy and distal pancreatectomy. Finally, man-
agement in 12 patients (8%) reported in the literature was
not described.
From our review, 64 patients (41%) with pseudoaneu-
rysm had concomitant pseudocyst. Interventions in this
group included splenectomy and distal pancreatectomy in
48%, transcatheter embolization in 24%, endovascular
stenting in 8%, ligation alone in 5%, splenectomy alone in
3%, and unknown treatment in 11%. Three patients (20%)
with pseudocyst underwent failed transcatheter emboliza-
tion as primary treatment of pseudoaneurysm, compared
with a 13% failure rate in patients without pseudocyst. The
average size of pseudoaneurysms without associated
pseudocyst in which transcatheter embolization failed was
4.2 cm, compared with 4.8 cm in those in which it was
successful.
Postintervention mortality was 5% (8 patients). Mean
follow-up of 27.5 months (range, 1-180 months) was
obtained for 49 patients. All patients were doing well with
no reported aneurysm recurrence.
Of the eight pseudoaneurysms (5%) managed conser-
vatively, four were found to have spontaneously throm-
bosed at follow-up. Outcome of the other four pseudoan-
eurysms was not described.
DISCUSSION
Visceral artery pseudoaneurysm is rare. Over 18 years at
our institution only 37 pseudoaneurysms were identified,
and 10 involved the splenic artery. Review of the literature
supports the rarity of these lesions. Although more than
3000 visceral artery aneurysms have been reported in the
literature, only 157 splenic artery pseudoaneurysms have
been identified. While uncommon, a vascular surgeon may
still see several in his or her career. A good understanding of
the risk factors, presenting symptoms, diagnostic studies,
and treatment options is therefore necessary.
Pancreatitis in both acute and chronic forms is the cause
of most splenic artery pseudoaneurysms. A large proportion
of patients have a significant history of alcohol intake.
Pseudoaneurysm formation by this mechanism has been
attributed to digestion of the splenic artery by pancreatic
enzymes.58 The arterial wall subsequently weakens, form-
ing a pseudoaneurysm.
Posttraumatic pseudoaneurysm formation in the
splenic artery has been documented.23 Rapid deceleration
results in damage to the intima and elastic lamina of the
splenic artery, predisposing to pseudoaneurysm forma-
tion.40 Because nonoperative therapy of blunt splenic inju-
ries has been widely accepted, it is possible that there will be
an increasing incidence of splenic artery pseudoaneu-
rysm.61 Whether this is due to an actual increase in the
number of splenic artery pseudoaneurysms or to increased
detection (because of the frequent number of follow-up
CT scans) we do not know. When a splenic injury is
identified in these patients, they are frequently followed up
with CT until resolution of the splenic injury. Time from
injury until diagnosis of pseudoaneurysm ranges from 1 day
to 4 months (median, 4 days), and most are diagnosed
before the patient is discharged from the hospital.
Peptic ulcer disease is a rare cause of splenic artery
pseudoaneurysm; only three cases have been reported. Iat-
rogenic splenic artery pseudoaneurysm is also rare, and
presumed due to injury to the vessel during exploration. In
a small number of splenic artery pseudoaneurysms, there is
no identifiable cause.
Presentation of splenic artery pseudoaneurysm varies
from an incidental finding to acute hemodynamic collapse
in some patients.16 Hemorrhage from splenic artery pseu-
doaneurysm can lead to massive bleeding into the perito-
neal cavity, retroperitoneal space, adjacent organs, or pan-
creatic duct.47 Rupture into a pseudocyst is probably
responsible for formation of larger pseudoaneurysms.
Hemorrhage into the pancreatic duct by this mechanism
has been termed hemosuccus pancreaticus,72 and can result
in hematemesis, hematochezia, or melanotic stool.24 In our
review of the literature, hemorrhage was the most common
finding in patients with pseudoaneurysm of the splenic
artery. In addition, 58% of patients with bleeding are he-
modynamically unstable at presentation. The most com-
mon site of bleeding was the pancreatic duct; however, a
substantial number of patients had bleeding into the stom-
ach, colon, and peritoneal cavity.
Because of the rare nature of these lesions, prompt
diagnosis is a challenge.62 Many patients have chronic
alcoholism, and therefore physicians are led to believe the
symptoms are due to other, more common manifestations
of the disease.57 From our review, median time from acute
Table III. Studies used to diagnose splenic artery
pseudoaneurysm
Study
Current
series (%)
(N  10)
Literature
review (%)
(N  140)
Combined (%)
(N  150)
Angiography 30 52.9 51.3
CT 50 34.3 35.3
CT angiography 0 0.7 0.7
MRI 0 0.7 0.7
Ultrasound 0 3.6 3.3
Plain radiography 0 0.7 0.7
Endoscopy 10 0 0.7
Laparotomy or autopsy 10 6.4 6.7
CT, Computed tomography; MRI, magnetic resonance imaging.
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presentation to diagnosis of pseudoaneurysm was less than
24 hours; however, patients may be seen weeks, months,
and even years before, with symptoms related to pseudo-
aneurysm that may be misdiagnosed at that time. Posttrau-
matic pseudoaneurysm typically is diagnosed while the
patient is still in the hospital recovering from injury. How-
ever, patients may have symptoms related to pseudoaneu-
rysm months after injury, especially if they did not seek
medical attention immediately after injury.40
Diagnosis is best established with either CT or ultra-
sound; however, small pseudoaneurysms may be missed.73
In our review, even hemodynamically unstable patients
were usually able to undergo some form of radiologic study
before intervention, contrary to previous belief.57 Early
consultation with a surgeon and sound surgical judgment
should be used before performing angiography in an un-
stable patient. CT was commonly used to establish the
diagnosis; however, it does not offer the benefit of thera-
peutic maneuvers. When using CT for diagnosis, contrast
medium should be used to enhance the lumen and aid in
detection of smaller pseudoaneurysms.27 Ultrasound has
been used in several patients, and offers the benefit of
greater availability, lower cost, real-time capability, and no
need for contrast material.29 In addition, Doppler scanning
enables confirmation of the neck of the pseudoaneurysm, as
do color flow studies, providing the pseudoaneurysm has
flow. With either CT or ultrasound, pseudoaneurysms may
be mistaken for pseudocysts or other peripancreatic fluid
collections. High density within a peripancreatic fluid col-
lection should raise the suspicion of clot within a pseudo-
aneurysm. The most commonly used, and most reliable
study, is angiography, which allows the benefit of trans-
catheter embolization in appropriate patients. Thus all pa-
tients should undergo angiography if tolerable. Unstable
patients are best managed in the operating room. However,
there are many reports of successful transcatheter emboli-
zation in hemodynamically unstable patients, indicating
that this may be a viable option in selected patients. Other
methods, such as CT angiography and magnetic resonance
angiography, may offer better resolution along with dy-
namic imaging; however, they do not allow concurrent
therapeutic interventions.
Various interventions have been performed for both
ruptured and intact pseudoaneurysms. The most durable
procedure was splenectomy with or without distal pancre-
atectomy, which resulted in no reported failure. Ligation
alone was performed in a small number of patients, but with
a high failure rate (43%). Transcatheter embolization was
performed in 37% of reported cases, and was unsuccessful in
14%. Of the eight patients in whom transcatheter emboli-
zation failed, seven underwent successful surgical interven-
tions and one underwent a second transcatheter emboliza-
tion, which was successful. Of interest, among patients
without associated pseudocyst, there was no difference in
pseudoaneurysm diameter in patients in whom emboliza-
tion failed and those in whom embolization was successful.
This suggests that pseudoaneurysm diameter is not a pre-
dictor of success or failure of transcatheter embolization. If
transcatheter embolization of pseudoaneurysm is chosen,
most authors recommend embolization of only the feeding
vessels, which will result in pseudoaneurysm thrombosis.
For this procedure, the artery from which the pseudoaneu-
rysm originates is selectively catheterized and embolized
with coils just distal and proximal to the lesion. This effec-
tively excludes the aneurysm from the circulation and en-
ables thrombosis. In addition, because the pseudoaneu-
rysm wall is thin, this method averts possible
pseudoaneurysm rupture by the embolizing agent.17 Care
must be taken to spare the collateral circulation supplying
the spleen, to avert splenic infarction. If transcatheter em-
bolization is not feasible and the patient continues to bleed,
positioning a balloon occlusion catheter in the splenic
artery may slow the bleeding before surgery.74 Complica-
tions reported after transcatheter embolization include
pain, pancreatic abscess, splenic infarction, splenic abscess,
and death, all of which are rare.
Pseudoaneurysm related to pseudocyst formation is
best treated with surgical excision, rather than transcatheter
embolization, because of the difficulty of embolizing large
pseudocyst cavities.55,74 A substantial number of patients
(41%) have associated pseudocyst. From this group of
patients, most (48%) have undergone splenectomy and
distal pancreatectomy, with no reported failure. In contrast,
embolization failed in a substantial number of patients
(20%) with pseudocyst compared with patients without
pseudocyst (13%). In patients with pseudocyst, transcathe-
ter embolization may be appropriate for pseudoaneurysm
that ruptures within the pseudocyst, to improve hemody-
namic status, enabling less urgent surgical intervention.48
Pseudoaneurysm size is not a determinant of rupture;
both the smallest (0.3 cm) and largest (17 cm) pseudoan-
eurysms reported were ruptured at presentation. In addi-
tion, only 2.5% of reported pseudoaneurysms are asymp-
tomatic. In our series of 10 patients, 80% of whom had
symptoms, the average pseudoaneurysm was substantially
smaller than reported in the literature (1.7 vs 5.0 cm).
Finally, because the natural history of asymptomatic splenic
artery pseudoaneurysm is unknown, we recommend repair
of all splenic artery pseudoaneurysms, regardless of size or
symptoms.
CONCLUSION
Splenic artery pseudoaneurysm is an uncommon vascu-
lar lesion. Most are caused by pancreatic disease; however,
trauma is also a common cause. Although transcatheter
embolization has gained acceptance for treatment of other
visceral aneurysms, it carries a significant failure rate when
used for pseudoaneurysm of the splenic artery, especially
when there is associated pseudocyst. Splenectomy, with or
without pancreatectomy, has proved durable, with no re-
ported failure, and remains the current standard of treat-
ment for these vascular lesions. Although conservative
management has produced excellent results in a few re-
ports, from our experience and the literature, we recom-
mend that all splenic artery pseudoaneurysms be repaired,
regardless of size or symptoms.
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